Volpara to distribute AI decision support software for breast cancer detection
Wellington-based medical technology company Volpara Health Technologies has signed a distribution agreement with Dutch firm ScreenPoint Medical to distribute its Transpara artificial intelligence solution for mammography in Australia and New Zealand.
Transpara is described as next-generation computer-aided detection software that has been designed to help radiologists read screening mammograms by marking specific areas of the breast image as likely to be cancer or not.
Posted in New Zealand eHealth
Tags: Volpara
You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.